v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total
Balances, Beginning at Dec. 31, 2024 $ 253 $ 608,354 $ (537,346) $ (206) $ 71,055
Balances, Beginning (in shares) at Dec. 31, 2024 25,324,684        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options $ 2 415     417
Exercise of stock options (in shares) 183,846        
Employee stock compensation   2,455     2,455
Issuance of common stock, net of costs $ 6 9,192     9,198
Issuance of common stock, net of costs (in shares) 543,462        
Net loss     (13,766)   (13,766)
Cumulative translation adjustment       1 1
Balances, Ending at Mar. 31, 2025 $ 261 620,416 (551,112) (205) 69,360
Balances, Ending (in shares) at Mar. 31, 2025 26,051,992        
Balances, Beginning at Dec. 31, 2024 $ 253 608,354 (537,346) (206) 71,055
Balances, Beginning (in shares) at Dec. 31, 2024 25,324,684        
Balances, Ending at Dec. 31, 2025 $ 263 629,916 (590,652) (203) 39,324
Balances, Ending (in shares) at Dec. 31, 2025 26,311,607        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   32     $ 32
Exercise of stock options (in shares) 36,500       36,500
Vesting of restricted stock units $ 1 (1)      
Vesting of restricted stock units (in shares) 80,660        
Employee stock compensation   2,916     $ 2,916
Issuance of common stock, net of costs   (43)     (43)
Net loss     (13,120)   (13,120)
Balances, Ending at Mar. 31, 2026 $ 264 $ 632,820 $ (603,772) $ (203) $ 29,109
Balances, Ending (in shares) at Mar. 31, 2026 26,428,767